Vaxinano
PrivateLast Round
Seed
Oct 29, 2024
Total Funding Raised
$7.09M
Company Overview
Vaxinano is a biotechnology company that develops prophylactic and therapeutic nasal vaccines intended to treat infectious diseases for human and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxinano Comparables
Compare Vaxinano with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lovaltech | 80% | |
| POP Biotechnologies, Inc. | 78% | |
| Xanadu Bio | 78% | |
Vaxinano Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2024 | ||||
| Grant | Jun 1, 2020 | ||||
| Seed | Jun 22, 2017 |
Key People
Founding team and executive leadership
Vaxinano Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
| Bpifrance | Seed |
| WiSeed | Seed |
| TCD Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
$6.46M raised from Finorpa and Nord France Amorquage.
Vaxinano Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vaxinano's valuation, stock price, and market status.